1-3 of 3
Nigel Bundred
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Nigel Bundred, Nuria Porta, Adrian Murray Brunt, Angela Cramer, Andrew Hanby, Abeer M. Shaaban, Emad A. Rakha, Anne Armstrong, Ramsey I. Cutress, David Dodwell, Marie A. Emson, Abigail Evans, Sue M. Hartup, Kieran Horgan, Sarah E. Miller, Stuart A. McIntosh, James P. Morden, Jay Naik, Sankaran Narayanan, Jane Ooi, Anthony I. Skene, David A. Cameron, Judith M. Bliss
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1323–1334.
https://doi.org/10.1158/1078-0432.CCR-21-3177
Published: 01 April 2022
View article titled, Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Open the PDF for Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results in another window
Includes: Supplementary data
Journal Articles

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)

Alexandra Leary, Abigail Evans, Stephen R.D. Johnston, Roger A'Hern, Judith M. Bliss, Rashmita Sahoo, Simone Detre, Benjamin P. Haynes, Margaret Hills, Catherine Harper-Wynne, Nigel Bundred, Gill Coombes, Ian Smith, Mitch Dowsett
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (13): 2932–2940.
https://doi.org/10.1158/1078-0432.CCR-14-1428
Published: 30 June 2015
View article titled, Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)
Open the PDF for Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039) in another window
Includes: Supplementary data
Journal Articles

Coexpression of Parathyroid Hormone Related Protein and Its Receptor in Early Breast Cancer Predicts Poor Patient Survival

Richard Linforth, Neil Anderson, Richard Hoey, Tania Nolan, Sarah Downey, Gerard Brady, Linda Ashcroft, Nigel Bundred
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3172–3177.
Published: 01 October 2002
View article titled, Coexpression of Parathyroid Hormone Related Protein and Its Receptor in Early Breast Cancer Predicts Poor Patient Survival
Open the PDF for Coexpression of Parathyroid Hormone Related Protein and Its Receptor in Early Breast Cancer Predicts Poor Patient Survival in another window